Walgreens Boots Alliance, Inc.’s Stock Price Plummets to $10.20, Marking a 4.49% Drop: An In-depth Analysis

Walgreens Boots Alliance, Inc. (WBA)

10.20 USD -0.48 (-4.49%) Volume: 14.02M

Walgreens Boots Alliance, Inc.’s stock price stands at 10.20 USD, witnessing a fall of -4.49% in this trading session with a trading volume of 14.02M, reflecting a significant YTD decline of -60.93%, indicating a turbulent year for WBA’s market performance.

Latest developments on Walgreens Boots Alliance, Inc.

Following a tumultuous period for Walgreens Boots Alliance, Inc. (NASDAQ:WBA), which saw a significant US$691 million market cap drop and the company reaching a new 52-week low at $10.56, institutional owners may be facing tough decisions. With a class action filed against Walgreens Boots Alliance, Inc. (WBA) and rumors swirling about the potential sale of its VillageMD business, investors are on high alert. Manning & Napier Advisors LLC recently invested $1.21 million in Walgreens Boots Alliance, Inc. (NASDAQ:WBA), while legal firms like Glancy Prongay & Murray LLP and ROSEN are reminding investors of looming deadlines. The stock price movements today are reflective of the uncertainty surrounding the company’s future.

Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma, such as Baptista Research, have been closely monitoring Walgreens Boots Alliance‘s performance. In one report titled “Enhancing Digital & Operational Efficiency To Expand Margins! – Major Drivers,” they highlighted the mixed outcomes in various areas of the company’s businesses during the third quarter of Fiscal Year 2024. The report aims to provide a comprehensive view of the positive developments and drawbacks evident in the quarter under review.

Another report by Baptista Research, titled “Redefining Relationships & Creating Value with Payers! – Major Drivers,” analyzed the company’s second-quarter operational results. Despite ongoing challenges in the U.S. retail environment, Walgreens Boots Alliance reported an adjusted EPS of $1.20, reflecting discipline in cost and good execution in the U.S. Retail Pharmacy segment. The report also evaluates different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation using a Discounted Cash Flow methodology.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance has received high scores in the Value and Dividend categories, indicating a positive long-term outlook in terms of financial stability and returns for investors. The company’s strong focus on providing value to its shareholders and consistent dividend payments make it an attractive investment option in the retail drugstore industry.

However, the lower scores in Growth, Resilience, and Momentum suggest that Walgreens Boots Alliance may face challenges in terms of expanding its business, adapting to market changes, and maintaining a competitive edge in the industry. Despite these concerns, the company’s overall outlook remains optimistic, thanks to its solid foundation and commitment to delivering value to its stakeholders.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma